Leah Witt, MD: Hello. I'm Dr Leah Witt. Welcome back to season one of the Medscape inDiscussion chronic obstructive pulmonary disease (COPD) podcast series. Today, we're talking pulmonary rehab, the ...

Your care for non-small-cell lung cancer (NSCLC) doesn’t end when you finish your medical therapy. Once you’ve gone through your course of treatment – which could involve a combination of surgery, ...

Rehabilitation for lung cancer patients is a common part of improving lung function in people with the disease. Increasingly, pre-rehabilitation, which occurs after a lung cancer diagnosis but before ...

NASHVILLE, Tenn. -- In patients with significant respiratory disability following hospitalizations for COVID, 8 weeks of daily, supervised pulmonary rehabilitation was associated with significant ...

PHILADELPHIA (WPVI) -- For those with breathing problems, exercise may seem out of the question. But they can and should be active, under the guidance of pulmonary rehab, a therapy experts at Temple ...

The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend ...

TUCSON, Ariz. (KGUN) — A heart attack can happen anywhere and at any time. People recovering from a heart-related incident or even a serious lung illness need proper care to get back to normal.

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

Results from a study on an investigational combination treatment for patients with advanced KRAS G12C+ non-small cell lung ...

Akeso’s Phase 3 ASCO data show ivonescimab improved overall survival vs PD-1 chemo in squamous NSCLC—key read for investors.